[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100515414":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":34,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":7,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Hunan Province Tumor Hospital","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Yongchang Zhang, MD","CONTACT","+8613873123436","zhangyongchang@csu.edu.cn",{"name":15,"role":11,"phone":12,"phoneExt":7,"email":16},"Nong Yang, MD","yangnong0217@163.com",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":7,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Hunan Cancer hospital","RECRUITING","Changsha","Hunan","China","CN",{"type":26,"coordinates":27},"Point",[28,29],112.97087,28.19874,{"lat":29,"lon":28},[32],{"name":10,"role":11,"phone":33,"phoneExt":7,"email":13},"+86 731 89762321",{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Yongchang Zhang","Professor, Deputy Director of Thoracic Oncology Department","100515414",false,"NCT05991193","A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer","A Non-interventional Study and Its Clinical Relevance With Central Nervous System Metastatic Epidermal Growth Factor Receptor Mutation Positive Non-small Cell Lung Cancer","Inclusion Criteria:\n\n* Patients must be ≥18 years.\n* Provision of fully informed consent prior to any study specific procedures.\n* Patient with EGFR 19Del or L858R mutation diagnosed histologically or cytologically. The mutations above may exist alone or together.\n* Patients must have untreated advanced Non-Small Cell Lung Cancer (NSCLC).\n* According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":47,"type":48},100,"ESTIMATED","OBSERVATIONAL","This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.",[52],"NSCLC","2024-09-17",{"date":55,"type":56},"2024-09-20","ACTUAL",{"date":58,"type":56},"2023-12-29",{"date":60,"type":48},"2025-12-31",{"name":5,"class":6},1]